- Introduction of New CEO Cynthia Pussinen and Recently Appointed Chief business Officer, Dr. Modestus Obochi, on September 15, 2023 -
- Business Update, Strategy & Outlook Call on October 5, 2023 -
LONDON, Ontario and WINDHAM COUNTY, Conn., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced it will host two investor and analyst conference calls, with corresponding live webcasts.
The first of these two events will introduce the newly appointed CEO, Cynthia Pussinen, as well as the recently appointed Chief Business Officer, Dr. Modestus Obochi, Ph.D., MBA, and will discuss the overall vision of both executives to deliver novel medical therapies to patients. The second in this series of calls is intended to provide an overall business update and discuss the strategy and operating plans going forward. Details of each event are as follows:
CEO Introduction:
Date: Friday, September 15, 2023
Time: 10:00 a.m. Eastern Time.
Dial-In: 1-877-704-4453
Conference ID: 13741199
Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1634340&tp_key=29a41cab17
Business Update:
Date: Thursday, October 5, 2023
Time: 10:00 a.m. Eastern Time.
Dial-In: 1-877-704-4453
Conference ID: 13741177
Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1634043&tp_key=195a900d23
The October 5 event will conclude with a question-and-answer component, and investors can also email questions in advance to info@sernova.com. The company will answer as many questions as allowable within the given time constraints. Subsequently, replays of each event will be available on the events section of the Company's website at www.sernova.com.
ABOUT SERNOVA CORP. AND THE CELL POUCH SYSTEM PLATFORM FOR CELL THERAPY
Sernova Corp. is a clinical-stage biotechnology company that is ...